Mitsubishi UFJ Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $321M | Buy |
647,193
+49,696
| +8% | +$22M | 0.18% | 101 |
|
|
2026
Q1 | $267M | Buy |
597,497
+31,270
| +6% | +$14.6M | 0.18% | 108 |
|
|
2025
Q4 | $256M | Buy |
566,227
+21,249
| +4% | +$9.16M | 0.17% | 108 |
|
|
2025
Q3 | $213M | Buy |
544,978
+20,053
| +4% | +$8.38M | 0.15% | 121 |
|
|
2025
Q2 | $234M | Buy |
524,925
+35,858
| +7% | +$16.5M | 0.19% | 109 |
|
|
2025
Q1 | $237M | Buy |
489,067
+50,976
| +12% | +$23.8M | 0.22% | 101 |
|
|
2024
Q4 | $178M | Buy |
438,091
+32,739
| +8% | +$15.2M | 0.17% | 115 |
|
|
2024
Q3 | $189M | Buy |
405,352
+33,871
| +9% | +$16.3M | 0.2% | 93 |
|
|
2024
Q2 | $174M | Buy |
371,481
+38,339
| +12% | +$16.6M | 0.21% | 93 |
|
|
2024
Q1 | $139M | Buy |
333,142
+57,727
| +21% | +$24.4M | 0.19% | 101 |
|
|
2023
Q4 | $113M | Buy |
275,415
+21,332
| +8% | +$7.88M | 0.2% | 99 |
|
|
2023
Q3 | $88.4M | Buy |
254,083
+21,257
| +9% | +$7.43M | 0.18% | 106 |
|
|
2023
Q2 | $81.9M | Buy |
232,826
+14,709
| +7% | +$4.96M | 0.17% | 110 |
|
|
2023
Q1 | $68.7M | Buy |
218,117
+21,230
| +11% | +$6.37M | 0.16% | 116 |
|
|
2022
Q4 | $56.3M | Buy |
196,887
+18,898
| +11% | +$5.76M | 0.15% | 125 |
|
|
2022
Q3 | $51.5M | Buy |
177,989
+16,591
| +10% | +$4.77M | 0.17% | 112 |
|
|
2022
Q2 | $45.5M | Buy |
161,398
+13,151
| +9% | +$3.52M | 0.2% | 104 |
|
|
2022
Q1 | $38.7M | Buy |
148,247
+12,079
| +9% | +$2.87M | 0.15% | 132 |
|
|
2021
Q4 | $30.3M | Buy |
136,168
+19,729
| +17% | +$3.84M | 0.12% | 161 |
|
|
2021
Q3 | $21.1M | Buy |
116,439
+11,348
| +11% | +$2.22M | 0.1% | 196 |
|
|
2021
Q2 | $21.2M | Buy |
105,091
+2,794
| +3% | +$584K | 0.12% | 180 |
|
|
2021
Q1 | $22M | Buy |
102,297
+11,792
| +13% | +$2.59M | 0.14% | 157 |
|
|
2020
Q4 | $21.4M | Buy |
90,505
+8,116
| +10% | +$1.86M | 0.17% | 130 |
|
|
2020
Q3 | $22.4M | Buy |
82,389
+17,917
| +28% | +$4.94M | 0.21% | 100 |
|
|
2020
Q2 | $18.7M | Buy |
64,472
+12,344
| +24% | +$3.35M | 0.21% | 96 |
|
|
2020
Q1 | $12.4M | Buy |
52,128
+1,050
| +2% | +$241K | 0.19% | 109 |
|
|
2019
Q4 | $11.1M | Buy |
51,078
+6,523
| +15% | +$1.32M | 0.15% | 146 |
|
|
2019
Q3 | $7.55M | Buy |
44,555
+1,825
| +4% | +$323K | 0.12% | 176 |
|
|
2019
Q2 | $7.84M | Buy |
42,730
+8,454
| +25% | +$1.48M | 0.13% | 155 |
|
|
2019
Q1 | $6.3M | Buy |
34,276
+2,082
| +6% | +$385K | 0.13% | 151 |
|
|
2018
Q4 | $5.27M | Sell |
32,194
-2,464
| -7% | -$427K | 0.13% | 156 |
|
|
2018
Q3 | $6.68M | Sell |
34,658
-1,072
| -3% | -$191K | 0.14% | 148 |
|
|
2018
Q2 | $6.07M | Buy |
35,730
+52
| +0.1% | +$8.06K | 0.13% | 156 |
|
|
2018
Q1 | $5.82M | Sell |
35,678
-3,433
| -9% | -$561K | 0.13% | 157 |
|
|
2017
Q4 | $5.95M | Buy |
39,111
+1,578
| +4% | +$234K | 0.13% | 166 |
|
|
2017
Q3 | $5.71M | Buy |
37,533
+1,108
| +3% | +$167K | 0.13% | 163 |
|
|
2017
Q2 | $4.69M | Sell |
36,425
-4,173
| -10% | -$502K | 0.12% | 188 |
|
|
2017
Q1 | $4.44M | Buy |
40,598
+1,435
| +4% | +$126K | 0.1% | 208 |
|
|
2016
Q4 | $2.93M | Buy |
39,163
+980
| +3% | +$79.7K | 0.07% | 290 |
|
|
2016
Q3 | $3.33M | Buy |
38,183
+1,324
| +4% | +$125K | 0.08% | 251 |
|
|
2016
Q2 | $3.17M | Buy |
36,859
+1,150
| +3% | +$99.4K | 0.08% | 252 |
|
|
2016
Q1 | $2.84M | Buy |
35,709
+3,215
| +10% | +$291K | 0.08% | 264 |
|
|
2015
Q4 | $4.09M | Buy |
32,494
+1,927
| +6% | +$233K | 0.12% | 167 |
|
|
2015
Q3 | $3.18M | Buy |
30,567
+45
| +0.1% | +$5.78K | 0.1% | 199 |
|
|
2015
Q2 | $3.77M | Sell |
30,522
-1,807
| -6% | -$228K | 0.12% | 179 |
|
|
2015
Q1 | $3.81M | Sell |
32,329
-1,491
| -4% | -$179K | 0.11% | 192 |
|
|
2014
Q4 | $4.16M | Sell |
33,820
-4,225
| -11% | -$476K | 0.13% | 177 |
|
|
2014
Q3 | $4.27M | Sell |
38,045
-7,879
| -17% | -$750K | 0.13% | 177 |
|
|
2014
Q2 | $4.35M | Buy |
45,924
+249
| +0.5% | +$17.5K | 0.11% | 204 |
|
|
2014
Q1 | $3.23M | Buy |
45,675
+2,536
| +6% | +$201K | 0.09% | 256 |
|
|
2013
Q4 | $3.17M | Sell |
43,139
-8,162
| -16% | -$568K | 0.09% | 242 |
|
|
2013
Q3 | $3.89M | Buy |
51,301
+3,801
| +8% | +$302K | 0.1% | 232 |
|
|
2013
Q2 | $3.79M | Buy |
+47,500
| New | +$3.5M | 0.11% | 218 |
|
Other funds holding VRTX
Mitsubishi UFJ Asset Management's VRTX Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 8.3% in Q2 2026, buying an estimated $22M and bringing the position to 647,193 shares worth $321M. The position accounts for 0.18% of the portfolio, ranked #101.
Mitsubishi UFJ Asset Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Mitsubishi UFJ Asset Management held 647,193 shares of Vertex Pharmaceuticals worth $321M as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 49,696 Vertex Pharmaceuticals shares in Q2 2026, an estimated $22M.
- Vertex Pharmaceuticals made up 0.18% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #101 holding.
- Mitsubishi UFJ Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.